These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10309635)

  • 1. On narrowing the patient-doctor communications gap.
    FDA Consum; 1982 May; 16(4):19-21. PubMed ID: 10309635
    [No Abstract]   [Full Text] [Related]  

  • 2. AMA readies its version of the PPI.
    Med World News; 1982 May; 23(11):61, 64. PubMed ID: 10255687
    [No Abstract]   [Full Text] [Related]  

  • 3. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA proposes patient package inserts for most drugs.
    Mayberger HW; Bell BJ
    Leg Aspects Med Pract; 1979 Oct; 7(10):42-4. PubMed ID: 263192
    [No Abstract]   [Full Text] [Related]  

  • 5. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 6. Will PPIs affect your patients' attitudes?
    Patient Care; 1979 Feb; 13(3):190-1, 195-6. PubMed ID: 10240261
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient product information.
    Herxheimer A
    Therapie; 1994; 49(1):15-6. PubMed ID: 8091359
    [No Abstract]   [Full Text] [Related]  

  • 8. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served?
    J Tenn Med Assoc; 1972 Aug; 65(8):748-51. PubMed ID: 4671687
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient package inserts: a symposium. Introduction.
    Barclay WR
    Trans Stud Coll Physicians Phila; 1977 Jul; 45(1):2-3. PubMed ID: 617240
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug labeling for laymen?
    Regier H
    J Leg Med (N Y); 1976 Jan; 4(1):15-6. PubMed ID: 1082471
    [No Abstract]   [Full Text] [Related]  

  • 12. Doctor orders prescription for physicians, patient education.
    Hosp Patient Relat Rep; 1992 Jun; 7(6):2-3. PubMed ID: 10119314
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA electronic drug labels to improve patient safety.
    J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334
    [No Abstract]   [Full Text] [Related]  

  • 14. The patient medication instruction (PMI) leaflet: regulatory and evidentiary ramifications.
    Yacura M
    Spec Law Dig Health Care (Mon); 1986 Mar; 8(1):7-27. PubMed ID: 10276993
    [No Abstract]   [Full Text] [Related]  

  • 15. Bridging the gap: the patient-doctor relationship.
    Rozenbaum W'
    Pneumonol Alergol Pol; 2009; 77(3):314-9. PubMed ID: 19591106
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative efficacy.
    Stetler CJ
    J Med Assoc Ga; 1972 Sep; 61(9):312-5. PubMed ID: 5080001
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing drug information for patients.
    Hecht A
    FDA Consum; 1977 Sep; 11(7):16-9. PubMed ID: 10304999
    [No Abstract]   [Full Text] [Related]  

  • 19. The legal status of patient package inserts.
    Whitman JA
    Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
    [No Abstract]   [Full Text] [Related]  

  • 20. Some patients may receive too much information about prescriptions.
    Lavine G
    Am J Health Syst Pharm; 2009 Apr; 66(8):696-7. PubMed ID: 19336824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.